Related Experiment Video
Updated: Aug 9, 2026
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Rapid diagnosis of tuberculous meningitis by a dot-immunobinding assay
M G Sumi1, M Annamma, C Sarada
1Department of Pathology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kerala State, India.
Insights
A new dot-immunobinding assay (Dot-Iba) aids rapid diagnosis of tuberculous meningitis (TBM). This method accurately detects antimycobacterial antibodies in cerebrospinal fluid (CSF), proving effective even in resource-limited settings.
Area of Science:
- Immunology
- Infectious Diseases
- Neuroscience
Background:
- Tuberculous meningitis (TBM) diagnosis remains challenging, often requiring invasive procedures.
- Rapid and accurate diagnostic tools for TBM are crucial for timely treatment and improved patient outcomes.
- Current diagnostic methods for TBM can be slow and lack sensitivity, particularly in resource-limited settings.
Purpose of the Study:
- To standardize a dot-immunobinding assay (Dot-Iba) for detecting antimycobacterial antibodies in cerebrospinal fluid (CSF).
- To evaluate the diagnostic accuracy of Dot-Iba for tuberculous meningitis (TBM).
- To establish a simple, rapid, and specific method for TBM diagnosis suitable for routine laboratory use.
Main Methods:
- Standardization of a dot-immunobinding assay (Dot-Iba).
- Isolation of specific CSF-IgG antibodies to Mycobacterium tuberculosis.
- Immunoabsorbent affinity chromatography to isolate a 14 kDa antigen from M. tuberculosis culture filtrates.
- Quantification of specific antimycobacterial antibodies in CSF using Dot-Iba.
Main Results:
- The developed Dot-Iba correctly identified all 5 culture-proven TBM patients.
- The assay demonstrated no false positive results in CSF samples from patients with partially treated pyogenic meningitis.
- The method proved effective in quantifying specific antimycobacterial antibodies in CSF specimens.
Conclusions:
- The standardized Dot-Iba is a simple, rapid, and specific method for diagnosing tuberculous meningitis (TBM).
- This assay is well-suited for routine application in laboratories with limited resources.
- Dot-Iba offers a promising tool for the early and accurate laboratory diagnosis of TBM.
Abstract:
In this study, a dot-immunobinding assay (Dot-Iba) was standardized to measure circulating antimycobacterial antibodies in the cerebrospinal fluid (CSF) specimens for the rapid laboratory diagnosis of tuberculous meningitis (TBM). Specific CSF-IgG antibody to Mycobacterium tuberculosis from a culture proven patient with TBM was isolated and coupled with activated Cynogen bromide-Sepharose 4B. Using an immunoabsorbent affinity chromatography, 14 kDa antigen present in the culture filtrates of M. tuberculosis was isolated and this antigen was used in the Dot-Iba, to quantitate specific antimycobacterial antibodies in CSF specimens. The Dot-Iba gave positive results in all the 5 culture proven patients with TBM and gave no false positive results in CSFs from patients with partially treated pyogenic meningitis. Dot-Iba developed in our laboratory is a simple, rapid and specific method and more importantly suited for the routine application in laboratories with limited resources.
